Neurohacker Collective recently began a pilot study using the CBS Health platform powered by Cambridge Brain Sciences (CBS)—a leading provider of cognitive testing tools—to help customers receive quantitative feedback on their current brain health. In the initial pilot study, customers were self-selected and offered free cognitive testing with the purchase of Neurohacker Collective's nootropic, Qualia Mind. Participants were asked to complete the testing three times: before starting on Qualia Mind, after their first dose of Qualia Mind, and the final test after five days of using Qualia Mind.
The results for the 23 eligible subjects revealed meaningful improvement in core cognitive areas of reasoning, verbal ability and concentration. After 5 days of taking Qualia Mind, participants saw an average 85.4% increase in scores to measure ability to concentrate/avoid distraction, 37.2% increase in scores for planning skills, 31.1% increase in scores for visual representation, 16.9% increase in scores for verbal reasoning, 13.3% increase in scores for verbal short-term memory, and 10.2% increase in scores for episodic memory. While these are just preliminary findings on a small number of people, they are exciting initial results to see. For additional details on the study visit neurohacker.com/qualia-mind-pilot-study.